Alpha-fetoprotein-producing pancreatic acinar cell carcinoma

Journal of the Formosan Medical Association

Volumn 106, Issue 8, 2007, Pages 669-672

  Lin, Yang Chao ^a,b   Lee, Po Huang ^a   Yao, Yu Tung ^a   Hsiao, Jong Kai ^a   Sheu, Jin Chuan ^a   Chen, Chien Hung ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b TAIPEI CITY HOSPITAL   (Taiwan)

Author keywords

Acinar cell carcinoma; Pancreas; fetoprotein

Indexed keywords

ALPHA FETOPROTEIN; TUMOR MARKER;

ACINAR CELL CARCINOMA; ADULT; ARTICLE; CANCER RECURRENCE; CASE REPORT; CHRONIC HEPATITIS; DISEASE DURATION; FOLLOW UP; HEPATITIS B; HUMAN; HUMAN TISSUE; MALE; PANCREAS CARCINOMA; PANCREAS RESECTION; PANCREAS TUMOR; PROTEIN BLOOD LEVEL; SPLENECTOMY;

EID: 34548489682     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0929-6646(08)60025-X     Document Type: Article

References (17)

1. Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol 2001;2:533-43.
2. Chen CH, Chen DS. Hepatocellular carcinoma: 30 years' experience in Taiwan. J Formos Med Assoc 1992;91 (Suppl 3):S187-202.
3. Chen DS, Sung JL, Sheu IC, et al. Serum alpha-fetoprotein in the early stage of human hepatocellular carcinoma. Gastroenterology 1984;86:1404-9.
4. Sherman M. Alpha-fetoprotein: an obituary. J Hepatol 2001; 34:603-5.
5. Safi F, Roscher R, Beger HG. Tumor markers in pancreatic cancer. Sensitivity and specificity of CA 19-9. Hepatogastroenterology 1989;36:419-23.
6. Paspulati RM. Multidetector CT of the pancreas. Radiol Clin North Am 2005;43:999-1020.
7. Thompson NW, Eckhauser FE, Vinik AI, et al. Cystic neuroendocrine neoplasms of the pancreas and liver. Ann Surg 1984;199:158-64.
8. Filmus J, Capurro M. Glypican-3 and alphafetoprotein as diagnostic tests for hepatocellular carcinoma. Mol Diagn 2004;8:207-12.
9. Hartman GG, Ni H, Pickleman J. Acinar cell carcinoma of the pancreas. Arch Pathol Lab Med 2001;125:1127-8.
10. Sohn TA, Yea CJ, Cameron JL, et al. Resected adenocarcinoma of the pancreas - 616 patients: results, outcomes, and prognostic indicators. J Gastrointest Surg 2000;4: 567-79.
11. Benassai G, Mastrorilli M, Quarto G, et al. Survival after pancreaticoduodenectomy for ductal adenocarcinoma of the head of the pancreas. Chir Ital 2000;52:263-70.
12. Millikan KIN, Deziel DJ, Silverstein JC, et al. Prognostic factors associated with resectable adenocarcinorna of the head of the pancreas. Am Surg 1999;65:618-24.
13. Klimstra DS, Heffess CS, Oertel JE, et al. Acinar cell carcinoma of the pancreas. A clinicopathologic study of 28 cases. Am J Surg Pathol 1992;16:815-37.
14. Tatli S, Mortele KJ, Levy AD, et al. CT and MRI features of pure acinar cell carcinoma of the pancreas in adults. AJR Am J Roentgenol 2005;184:511-9.
15. Fritsche HA Jr, Gelder FB. Serum tumor markers for pancreatic carcinoma. Immunol Ser 1990;53:289-96.
16. Kawamoto S, Hiraoka T, Kanemitsu K, et al. Alpha-fetoprotein-producing pancreatic cancer - a case report and review of 28 cases. Hepatogastroenterology 1992;39: 282-6.
17. Kuopio T, Ekfors TO, Nikkanen V, et al. Acinar cell carcinoma of the pancreas. Report of three cases. Apmis 1995;103: 69-78.